Procyon Advisors LLC significantly increased its holdings in Intuitive Surgical, acquiring 4,254 additional shares in Q4, raising its total to 4,794 shares worth $2.7 million. This move reflects growing institutional confidence amid the company's strong quarterly earnings, with revenue up 18.8% year-over-year and earnings surpassing estimates. Despite some regulatory and operational challenges, Intuitive Surgical remains favored by analysts, with a consensus 'Moderate Buy' rating and an average target price near $615. The stock's recent technical weakness contrasts with its solid fundamentals and ongoing institutional buying activity.
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
